You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
未名醫藥(002581.SZ):持股5%以上股東高寶林擬減持不超6%公司股份
格隆匯 09-29 16:02

格隆匯 9 月 29日丨未名醫藥(002581.SZ)公佈,持股16.51%的股東高寶林計劃將於本公告披露之日起15個交易日後的六個月內通過集中競價方式、大宗交易方式或兩種方式相結合減持本公司股份,減持數量合計不超過3958.4135萬股,即減持比例不超過公司總股本的6%。其中,通過集中競價交易的,於本公告披露之日起15個交易日後的6個月內進行,任意連續90個自然日內通過集中競價交易減持股份的總數不超過公司股份總數的1%;通過大宗交易方式減持的,於本公告披露之日起的6個月內進行,任意連續90個自然日內通過大宗交易減持股份的總數不超過公司股份總數的2%。若減持期間公司有送股、資本公積金轉增股本等股份變動事項,減持股份數量進行相應調整。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account